Bone Marrow Derived Mesenchymal Stem Cells in Improving Heart Function in Patients With Heart Failure Caused by Anthracyclines

NCT02408432 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Cardiomyopathy
Heart Failure

Interventions

OTHER: Laboratory Biomarker Analysis
OTHER: Standard of Care
DRUG: Mesenchymal Stem Cell Transplantation

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]